Body mass index (BMI) and obesity in Nigerians with schizophrenia

References

• Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–814.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global health observatory (GHO) data: overweight and obesity. Geneva (Switzerland): WHO; 2018.
   Google Scholar
• Abubakari A-R, Bhopal RS. Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity in Ghanaians and Nigerians. Public Health. 2008;122(2):173–182.
   PubMed Web of Science ®Google Scholar
• Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431–1437.
   PubMed Web of Science ®Google Scholar
• Dinsa GD, Goryakin Y, Fumagalli E, et al. Obesity and socioeconomic status in developing countries: a systematic review. Obes Rev. 2012;13(11):1067–1079.
   PubMed Web of Science ®Google Scholar
• Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–689.
   PubMed Web of Science ®Google Scholar
• Biener AI, Cawley J, Meyerhoefer C. The medical care costs of obesity and severe obesity in youth: an instrumental variables approach. Health Econ. 2020;29(5):624–639.
   PubMed Web of Science ®Google Scholar
• Susce MT, Villanueva N, Diaz FJ, et al. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry. 2005;66(2):167–173.
   PubMed Web of Science ®Google Scholar
• Hui L, Ye M, Tang W, et al. Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: gender difference. Psychiatry Res. 2015;225(3):741–742.
   PubMed Web of Science ®Google Scholar
• Luckhoff HK, Kilian S, Olivier MR, et al. Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia. Metab Brain Dis. 2019;34(2):469–476.
   PubMed Web of Science ®Google Scholar
• Luckhoff H, Phahladira L, Scheffler F, et al. Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12months. Schizophr Res. 2019;206:171–176.
   PubMed Web of Science ®Google Scholar
• Strassnig M, Brar JS, Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res. 2003;62(1–2):73–76.
   PubMed Web of Science ®Google Scholar
• Hermes E, Nasrallah H, Davis V, et al. The association between weight change and symptom reduction in the CATIE schizophrenia trial. Schizophr Res. 2011;128(1–3):166–170.
   PubMed Web of Science ®Google Scholar
• Manu P, Dima L, Shulman M, et al. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand. 2015;132(2):97–108.
   PubMed Web of Science ®Google Scholar
• Gong S, Wang K, Li Y, et al. Geographic differences in obesity prevalence and its risk factors among Asian Americans: findings from the 2013-2014 California Health Interview Survey. Sci Rep. 2018;8(1):12510.
   PubMedGoogle Scholar
• Gupta N, Goel K, Shah P, et al. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocrine Rev. 2012;33(1):48–70.
   PubMed Web of Science ®Google Scholar
• Dao L, Dao F, Djekompté S, et al. Facteurs associés au surpoids et à l’obésité des élèves de Ouagadougou (Burkina Faso). Cahiers D’études et de Recherches Francophones/Santé. 2011;21(4):227–231.
   Google Scholar
• Pienaar AE. Prevalence of overweight and obesity among primary school children in a developing country: NW-CHILD longitudinal data of 6–9-yr-old children in South Africa. BMC Obesity. 2015;2(1):2.
   PubMedGoogle Scholar
• Teshome T, Singh P, Moges D. Prevalence and associated factors of overweight and obesity among high school adolescents in urban communities of Hawassa, Southern Ethiopia. Curr Res Nutr Food Sci. 2013;1(1):23–36.
   Google Scholar
• Catapano L, Castle D. Obesity in schizophrenia: what can be done about it? Australas Psychiatry. 2004;12(1):23–25.
   PubMedGoogle Scholar
• Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry. 2001;46(6):549–555.
   PubMed Web of Science ®Google Scholar
• Esan OB, Oladele O, Adediran KI, et al. Neurocognitive impairments (NCI) in bipolar disorder: comparison to schizophrenia and healthy controls. J Affect Disord. 2020;277:175–181.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• [25]. APA. Diagnostic and statistical manual of mental disorders. 4th ed. DSM-IV. Washington (DC): American Psychiatric Press; 1994.
   Google Scholar
• Andreasen NC, Carpenter WT, Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–449.
   PubMed Web of Science ®Google Scholar
• Amole IO, OlaOlorun AD, Odeigah LO, et al. The prevalence of abdominal obesity and hypertension amongst adults in Ogbomoso, Nigeria. Afr J Prm Health Care Fam Med. 2011;3(1):1–5.
   Google Scholar
• Akarolo-Anthony SN, Willett WC, Spiegelman D, et al. Obesity epidemic has emerged among Nigerians. BMC Public Health. 2014;14(1):455.
   PubMed Web of Science ®Google Scholar
• Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. 2009;28(5):822–831.
   PubMed Web of Science ®Google Scholar
• [30]. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601.
   PubMed Web of Science ®Google Scholar
• Silverstone T, Smith G, Goodall E. Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry. 1988;153:214–217.
   PubMed Web of Science ®Google Scholar
• Kumanyika S, Jeffery RW, Morabia A, et al. Obesity prevention: the case for action. Int J Obes. 2002;26(3):425–436.
   PubMed Web of Science ®Google Scholar
• Beebe LH. Obesity in schizophrenia: screening, monitoring, and health promotion. Perspect Psychiatr Care. 2008;44(1):25–31.
   PubMed Web of Science ®Google Scholar
• Central Intelligence Agency [Internet]. CIA - the world factbook. Fairfax (VA): CIA; 2009. Retrieved from teacherlink.ed.usu.edu/tlresources/reference/factbook/geos/countrytemplate_ni.html
   Google Scholar
• Levine JA. Poverty and obesity in the U.S. Diabetes. 2011;60(11):2667–2668.
   PubMed Web of Science ®Google Scholar
• Aitsi-Selmi A, Bell R, Shipley MJ, et al. Education modifies the association of wealth with obesity in women in middle-income but not low-income countries: an interaction study using seven national datasets, 2005-2010. PLoS One. 2014;9(3):e90403.
   PubMed Web of Science ®Google Scholar
• Li Q, Du X, Zhang Y, et al. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. Psychiatry Res. 2017;251:131–136.
   PubMed Web of Science ®Google Scholar
• Miard S, Picard F. Obesity and aging have divergent genomic fingerprints. Int J Obes. 2008;32(12):1873–1874.
   Web of Science ®Google Scholar
• Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5(2):144–164.
   PubMed Web of Science ®Google Scholar
• Lovejoy JC. The influence of sex hormones on obesity across the female life span. J Womens Health. 1998;7(10):1247–1256.
   PubMed Web of Science ®Google Scholar
• Riebe D, Blissmer BJ, Greaney ML, et al. The relationship between obesity, physical activity, and physical function in older adults. J Aging Health. 2009;21(8):1159–1178.
   PubMed Web of Science ®Google Scholar
• Ryan AS. Exercise in aging: its important role in mortality, obesity and insulin resistance. Aging Health. 2010;6(5):551–563.
   PubMedGoogle Scholar
• Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177–113.
   PubMed Web of Science ®Google Scholar